No Data
No Data
Retail Investors Who Hold 40% of Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) Gained 6.1%, Insiders Profited as Well
Key Insights Guangzhou Wondfo BiotechLtd's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public 50% of the business is held
Guangzhou Wondfo Biotech (300482.SZ): Currently focusing on toxicology business in the US market.
Guangzhou Wondfo Biotech (300482.SZ) stated on the investor interaction platform on July 10 that the company's business in the USA is currently mainly focused on drug testing. The company has been deeply cultivating the US market for many years, continuously strengthening the construction of the US drug testing market, and is committed to providing the most comprehensive drug testing solutions in the industry. At the same time, the company is also constantly promoting the import of respiratory testing products and promoting the continuous and stable growth of business in the US market.
Guangzhou Wondfo Biotech (300482.SZ): Plans to launch a 2024 restricted stock incentive program for 14.16 million shares.
On July 5th, Gelon Hui reported that Guangzhou Wondfo Biotech (300482.SZ) announced its 2024 restricted stocks incentive plan (draft). The plan intends to grant 14.16 million restricted stocks to the incentive recipients, accounting for approximately 3.00% of the company's total stock of 471.771537 million shares at the time of the announcement of this draft incentive plan. Of these, 13.39 million restricted stocks are granted for the first time, accounting for approximately 2.84% of the company's total stock of 471.771537 million shares at the time of the announcement of this draft incentive plan, representing 94.56% of the total number of restricted stocks to be granted under this incentive plan. Some restricted stocks are reserved.
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Firstly, we'll want to see a proven return on capital employed (ROCE) that is inc
Wanfu Biotech (300482.SZ) will distribute 4 yuan for every 10 shares in 2023. The stock registration date is June 4
Wanfu Biotech (300482.SZ) announced that the company will implement the 2023 annual equity distribution, for every 10 shares...
Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price Boosted 31% But Its Business Prospects Need A Lift Too
Guangzhou Wondfo Biotech Co.,Ltd (SZSE:300482) shares have had a really impressive month, gaining 31% after a shaky period beforehand. The bad news is that even after the stocks recovery in the las
No Data